Letter | Published:

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Nature Biotechnology volume 26, pages 101106 (2008) | Download Citation

Subjects

Abstract

Direct reprogramming of somatic cells provides an opportunity to generate patient- or disease-specific pluripotent stem cells. Such induced pluripotent stem (iPS) cells were generated from mouse fibroblasts by retroviral transduction of four transcription factors: Oct3/4, Sox2, Klf4 and c-Myc1. Mouse iPS cells are indistinguishable from embryonic stem (ES) cells in many respects and produce germline-competent chimeras2,3,4. Reactivation of the c-Myc retrovirus, however, increases tumorigenicity in the chimeras and progeny mice, hindering clinical applications3. Here we describe a modified protocol for the generation of iPS cells that does not require the Myc retrovirus. With this protocol, we obtained significantly fewer non-iPS background cells, and the iPS cells generated were consistently of high quality. Mice derived from Myc iPS cells did not develop tumors during the study period. The protocol also enabled efficient isolation of iPS cells without drug selection. Furthermore, we generated human iPS cells from adult dermal fibroblasts without MYC.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

  2. 2.

    et al. In vitro reprogramming of fibroblasts into a pluripotent ES cell-like state. Nature 448, 318–324 (2007).

  3. 3.

    , & Generation of germ-line competent induced pluripotent stem cells. Nature 448, 313–317 (2007).

  4. 4.

    et al. Directly reprogrammed fibroblasts show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).

  5. 5.

    et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).

  6. 6.

    et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631–642 (2003).

  7. 7.

    & POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 11, 1207–1225 (1997).

  8. 8.

    , & Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev. Cell 3, 167–170 (2002).

  9. 9.

    , & The biology of the mammalian Kruppel-like family of transcription factors. Int. J. Biochem. Cell Biol. 32, 1103–1121 (2000).

  10. 10.

    & Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635–645 (2005).

  11. 11.

    et al. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23, 2699–2708 (2003).

  12. 12.

    , & Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063–1066 (2000).

  13. 13.

    et al. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40, 241–246 (2004).

  14. 14.

    et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, published online, doi:10.1016/j.cell.2007.11.019 (20 November 2007).

  15. 15.

    et al. Induced pluripotent stem cell lines derived from human somatic cells. Science, published online, doi:10.1126/science.1151526 (20 November 2007).

  16. 16.

    et al. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 21, 1125–1138 (2007).

  17. 17.

    & The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1073–1085 (1990).

  18. 18.

    et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA 93, 14041–14046 (1996).

Download references

Acknowledgements

We thank K. Yae and M. Maekawa for their valuable scientific discussions; M. Narita for technical assistance; and R. Kato and R. Iyama for administrative assistance. We also thank K. Tomoda for the RNA of hES cells, T. Kitamura for the Plat-E cells and pMXs retroviral vectors, and R. Farese for the RF8 ES cells. This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO, a grant from the Leading Project of MEXT, a grant from Uehara Memorial Foundation and Grants-in-Aid for Scientific Research of JSPS and MEXT (to S.Y.). T. A. and K.O. are JSPS research fellows.

Author information

Author notes

    • Masato Nakagawa
    •  & Michiyo Koyanagi

    These authors contributed equally to this work.

Affiliations

  1. Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.

    • Masato Nakagawa
    • , Michiyo Koyanagi
    • , Koji Tanabe
    • , Kazutoshi Takahashi
    • , Tomoko Ichisaka
    • , Takashi Aoi
    • , Keisuke Okita
    • , Yuji Mochiduki
    • , Nanako Takizawa
    •  & Shinya Yamanaka
  2. CREST, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan.

    • Tomoko Ichisaka
    •  & Shinya Yamanaka
  3. Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.

    • Shinya Yamanaka
  4. Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan.

    • Shinya Yamanaka

Authors

  1. Search for Masato Nakagawa in:

  2. Search for Michiyo Koyanagi in:

  3. Search for Koji Tanabe in:

  4. Search for Kazutoshi Takahashi in:

  5. Search for Tomoko Ichisaka in:

  6. Search for Takashi Aoi in:

  7. Search for Keisuke Okita in:

  8. Search for Yuji Mochiduki in:

  9. Search for Nanako Takizawa in:

  10. Search for Shinya Yamanaka in:

Contributions

M.N., M.K., K.Tanabe, K.Takahashi, T.A. and K.O. generated and characterized iPS cells. T.I. performed the chimera experiments. Y.M. prepared plasmids. N.T. characterized iPS cells. S.Y. supervised the study and wrote the manuscript.

Corresponding author

Correspondence to Shinya Yamanaka.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Tables 1–3 and Figures 1–3

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nbt1374